Onco Life Hospitals

Bone cancer is among the rarer cancer diagnoses, but it is not a single disease. Osteosarcoma, Ewing's sarcoma, chondrosarcoma, giant cell tumour, and chordoma are primary bone tumours, each with distinct biology and treatment requirements. Metastatic bone disease, where cancers of the breast, lung, prostate, kidney, or thyroid spread to bone, is a different clinical situation requiring a different management approach. Finding a bone cancer specialist in Mumbai who can distinguish between these, and who works within a full oncology team rather than as a single surgeon, is the critical first decision after diagnosis.

Onco-Life Cancer Centre at Talegaon, 70 to 75 km from Mumbai via the Expressway, offers surgical oncology for bone tumours, SBRT (Stereotactic Body Radiotherapy) for bone metastases and localised primary tumours, and chemotherapy for osteosarcoma and Ewing's sarcoma. Every patient is reviewed by our Tumour Board before treatment is planned. For Mumbai patients with a bone cancer diagnosis, or with suspected bone involvement from another primary cancer, Onco-Life provides accessible specialist care without the waiting times common at large Mumbai hospitals.

Why Mumbai Patients Choose Onco-Life for Bone Cancer Treatment

Specialist Bone Tumour Surgery, Not General Orthopaedics
Primary bone tumours need an orthopaedic oncologist, not a general orthopaedic surgeon. Decisions on en bloc resection, surgical margins, limb-sparing surgery versus amputation, and skeletal reconstruction (endoprosthesis or bone grafting) are made by trained specialists at Onco-Life, with the full team reviewing the surgical plan beforehand.

Under 90 Minutes from Mumbai
Our Talegaon centre is 70-75 km from Mumbai via the Mumbai-Pune Expressway (75-90 minutes). Since bone cancer treatment often spans chemotherapy, surgery, and radiation over 6-9 months, easy access matters – many Mumbai patients travel for same-day consultations and chemo infusions.

NABH-Accredited with Advanced Radiation Tech
Onco-Life holds three NABH accreditations. For bone cancer, we offer SBRT for precise, high-dose targeting of bone lesions, PET-CT for staging and response assessment, and digital pathology for biopsy and margin analysis. Every case is reviewed by our Tumour Board before treatment.

Treating Both Primary Bone Tumours and Bone Metastases
We manage the full spectrum – from neoadjuvant chemotherapy and limb-sparing surgery for primary osteosarcoma, to palliative SBRT for bone metastases from cancers like breast cancer. Different pathways, same specialist team and infrastructure.

Types of Bone Cancer We Treat

Primary Bone Tumours

Primary bone cancers originate in the bone tissue itself. The main types treated at Onco-Life include:
  • Osteosarcoma: the most common primary malignant bone tumour, most frequently occurring in adolescents and young adults around the knee, shoulder, or hip. Standard treatment involves neoadjuvant chemotherapy (MAP or similar protocol) to shrink the tumour before surgery, followed by limb-sparing resection and adjuvant chemotherapy.
  • Ewing’s Sarcoma: a high-grade round cell sarcoma primarily affecting children and young adults, frequently in the long bones or pelvis. Treatment includes multi-agent chemotherapy, surgery, and radiation, often in combination.
  • Chondrosarcoma: a cartilage-forming bone tumour that affects adults, most commonly in the pelvis, femur, and shoulder. Surgery is the primary treatment; chondrosarcomas are relatively resistant to conventional chemotherapy.
  • Giant Cell Tumour of Bone: a locally aggressive benign or borderline malignant tumour, typically at the end of long bones near joints. Treatment involves curettage or resection and reconstruction; denosumab may be used in selected cases.
  • Chordoma: a rare tumour arising from notochordal remnants, typically in the sacrum or skull base. Treatment involves wide surgical resection and radiation, often requiring high-dose particle therapy or proton therapy for skull base cases.

Metastatic Bone Cancer (Bone Metastases)

Bone metastases occur when cancer originating in another organ spreads to bone. The most common primary cancers that spread to bone are breast, lung, prostate, kidney, and thyroid cancers. Treatment for bone metastases is different from primary bone cancer and focuses on pain control, prevention of skeletal complications (fractures, spinal cord compression), and local tumour control. At Onco-Life, we treat bone metastases with SBRT for localised disease, systemic therapy coordination, and surgical stabilisation where bone fracture risk is high.

Bone Cancer Treatment at Onco-Life Cancer Centre

Surgical Oncology: Limb-Sparing Surgery and Bone Reconstruction

Limb-sparing surgery (limb salvage) has become the standard surgical approach for primary bone tumours of the extremities in most cases, replacing amputation for eligible patients. The goals are complete oncological removal of the tumour with clear margins and preservation of the limb with functional reconstruction. Our surgical oncologists perform:

  • En bloc resection of primary bone tumours with planned oncological margins
  • Limb-salvage procedures with endoprosthetic reconstruction, bone graft, or a combination, depending on the defect size and location
  • Joint replacement surgery following tumour resection around the knee, hip, or shoulder
  • Surgical stabilisation of bones weakened by metastatic disease, including intramedullary nailing and prophylactic fixation to prevent fracture
  • Spinal surgery for vertebral metastases causing or risking spinal cord compression

The surgical approach is agreed at the Tumour Board before the operation, after reviewing all imaging, biopsy results, and the patient’s response to any neoadjuvant chemotherapy.

Radiation Oncology: SBRT for Bone Tumours and Metastases

Radiation therapy in bone cancer serves two distinct clinical purposes. For Ewing’s sarcoma, radiation is often part of the definitive treatment protocol alongside chemotherapy. For bone metastases, SBRT (Stereotactic Body Radiotherapy) provides highly targeted, high-dose radiation to a bone lesion in 1 to 5 sessions, achieving durable pain relief and local tumour control with minimal exposure to surrounding structures. At Onco-Life, our radiation capabilities for bone disease include:

  • SBRT for spine, pelvis, and long bone metastases: delivering ablative doses that achieve superior local control compared to conventional palliative radiation
  • Conventional palliative radiation: for patients with multiple bone metastases where the goal is pain control over a short course of fractions
  • Post-operative radiation for Ewing’s sarcoma: where surgical margins are involved or where surgery was not performed
  • Image guidance and motion management: ensuring precise targeting of bone lesions adjacent to the spinal cord, bowel, or other critical structures

Medical Oncology: Chemotherapy for Osteosarcoma and Ewing's Sarcoma

Systemic chemotherapy is an integral part of osteosarcoma and Ewing’s sarcoma management:

  • Osteosarcoma: neoadjuvant chemotherapy using high-dose methotrexate, doxorubicin, and cisplatin (MAP protocol) before surgery, followed by adjuvant chemotherapy after surgery. Histological response to neoadjuvant chemotherapy (percentage of tumour necrosis at resection) guides the post-surgical protocol.
  • Ewing’s Sarcoma: multi-agent chemotherapy with VDC/IE (vincristine, doxorubicin, cyclophosphamide alternating with ifosfamide and etoposide) given before and after local treatment.
  • Bone metastases from systemic cancers: coordination with the treating medical oncologist for the primary cancer’s systemic therapy, with bone-specific agents (denosumab, bisphosphonates) where appropriate.

All chemotherapy regimens are administered in our daycare infusion units. Toxicity monitoring is active at every cycle.

PET-CT Scan and Bone Imaging for Staging

Accurate staging is essential before any bone cancer treatment decision is made. For primary bone tumours, staging determines whether the disease is localised (resectable) or has spread to lungs, lymph nodes, or other bones. For metastatic bone disease, imaging determines the extent of skeletal involvement and informs the risk of fracture. At Onco-Life, PET-CT Scan is available at Talegaon and Pune. MRI of the primary tumour site, CT chest for pulmonary metastasis assessment, and bone scintigraphy are also coordinated on-site or through our network.

Multidisciplinary Tumour Boards

Bone tumour management is particularly dependent on multidisciplinary planning. The sequence of treatment, for example whether chemotherapy precedes surgery or surgery comes first, and whether radiation is part of the definitive plan, must be agreed before any intervention begins.

Our Tumour Board reviews every bone tumour case with the surgical oncologist, medical oncologist, radiation oncologist, radiologist, and pathologist present. For a diagnosis as rare and consequential as primary bone cancer, this coordinated review is not optional at Onco-Life.

Meet Our Bone Cancer Specialist Team

Dr. Sunil Patil

MBBS, MS (General Surgery)

Senior Consultant – Surgical Oncology

Onco-Life Cancer Centre, Satara

Veteran Surgical Oncologist with 23+ Years of Experience

Dr. Siddhesh Tryambake

M.B.B.S., M.D., D.N.B., DrNB

Consultant Clinical & Radiation Oncologist

Onco-Life Cancer Centre, Satara & T.G.H. Onco-Life Cancer Centre, Pune

Your Bone Cancer Care Journey at Onco-Life

Step 1: Initial Consultation and Biopsy Review

You meet with our bone tumour specialist who reviews your imaging (MRI, CT, bone scan or PET-CT), biopsy report, and pathology. We confirm the diagnosis and specific tumour type, assess the extent of disease, and explain the findings clearly. For suspected cases without a biopsy yet, we arrange a bone biopsy before any staging or treatment planning proceeds.

Step 2: Complete Staging

PET-CT Scan, CT chest for pulmonary metastasis assessment, bone scintigraphy, and MRI of the primary lesion are coordinated to establish complete staging. For osteosarcoma and Ewing's sarcoma, staging determines whether the patient has localised or metastatic disease, which directly affects the treatment protocol and prognosis.

Step 3: Tumour Board and Treatment Planning

Your case is reviewed at the Tumour Board. For primary bone tumours, the treatment sequence is agreed: neoadjuvant chemotherapy, then surgery, then adjuvant chemotherapy, or a different sequence based on the specific case. For bone metastases, the goals and modality are agreed. We explain the full plan before you consent.

Step 4: Treatment Delivery and Response Monitoring

Treatment is delivered at Onco-Life Talegaon. For osteosarcoma, response to neoadjuvant chemotherapy is assessed by imaging before surgery. The surgical specimen is analysed for histological response, which guides the post-operative protocol. SBRT sessions are delivered with daily imaging verification. All results are reviewed by the treating team.

Step 5: Long-Term Follow-Up and Surveillance

After completing active treatment, structured surveillance continues: MRI of the surgical site every 3 to 6 months for the first 2 years, CT chest for pulmonary metastasis monitoring, and clinical examination at regular intervals. For bone metastases patients, ongoing systemic treatment and pain management are coordinated throughout.

Why Choose Onco-Life for Bone Cancer Treatment in Mumbai?

Bone cancer is rare, but its treatment requires a coordinated team of oncologists, not a single specialist. At Onco-Life, you get:

  • Surgical oncology for primary bone tumours and limb-sparing procedures
  • SBRT for bone metastases and Ewing's sarcoma radiation
  • Full chemotherapy protocols for osteosarcoma and Ewing's sarcoma
  • Tumour Board review before every treatment decision
  • PET-CT Scan, MRI review, and bone biopsy at the same facility
  • Three NABH accreditations
  • National Cancer Grid member – protocols aligned with Tata Memorial Centre
  • Specialist oncologists, not general practitioners seeing occasional bone tumour cases
  • Accessible from Mumbai in 75 to 90 minutes via the Expressway
  • Transparent treatment costs and scheme coverage confirmed before you begin

Government Scheme Coverage for Bone Cancer Treatment

Mumbai patients who hold an MJPJAY (Mahatma Jyotiba Phule Jan Arogya Yojana) or PM-JAY (Ayushman Bharat) card may have bone cancer surgery, chemotherapy, and radiation therapy packages covered at Onco-Life at no out-of-pocket cost. CGHS and ECHS beneficiaries are also accepted. Call us with your scheme details and diagnosis and our Arogya Mitra coordinators will confirm coverage for your specific bone cancer type before you travel.

Accessing Onco-Life Cancer Centre from Mumbai

Talegaon (Nearest Centre to Mumbai – 75 to 90 Minutes)

Our Talegaon centre is the closest Onco-Life facility for Mumbai patients, located on the Mumbai-Pune Expressway corridor. From South Mumbai, Central Mumbai, and the western suburbs, the Expressway journey typically takes 75 to 90 minutes. The centre offers full bone cancer services: PET-CT Scan, surgical oncology, SBRT radiation, chemotherapy and targeted therapy, and pathology.

Wagholi, Pune (approximately 90 to 105 minutes from Mumbai)

Our Wagholi centre near Pune is accessible by car or by train to Pune followed by a short cab ride. Medical oncology, PET-CT Scan, and full diagnostic services are available here. Patients from parts of Mumbai who find the Pune route more practical can access services at this centre.

Telemedicine Before You Travel

If you have MRI images, a bone biopsy report, or a PET-CT report, our bone cancer specialist can review your case by video before you travel. Share your reports digitally and we will confirm what additional investigations are needed, advise on urgency, and tell you whether an in-person visit is immediately required.

Book Your Consultation Today

Bone cancer is rare, and finding a specialist team that manages it as a complete clinical problem, not just a surgical case, takes time in a city the size of Mumbai. Onco-Life's bone cancer team is accessible in under 90 minutes from Mumbai. We are ready to review your biopsy, plan your staging, and put a coordinated treatment plan in place without the delays that come with fragmented specialist care.

Ready to take the next step?

  • Call Talegaon (Nearest to Mumbai): 8128124067, 8128123067
  • Call Pune / Wagholi: 8128124067, 8128123067
  • Call Satara: 02162-350063, 7769004343, 7030362222
  • Call Chiplun: 7378958000, 9404240762
  • Book Online: https://oncolifehospitals.com/book-doctor-appointment/
  • Telemedicine Consultation: Speak with a bone cancer specialist online

We are here for you. A specialist bone cancer team is accessible from Mumbai. Let us help you get the right diagnosis and the right treatment plan in place.

Frequently Asked Questions

Best Bone Cancer Treatment Specialist in Mumbai-FAQs

Is Onco-Life Accessible From Mumbai For Bone Cancer Treatment?

Yes. Our Talegaon centre is 70 to 75 km from Mumbai, about 75 to 90 minutes by car via the Expressway. Telemedicine is available for an initial case review of imaging and biopsy reports before you travel.

What Is The Difference Between Primary Bone Cancer And Bone Metastases?

Primary bone cancer starts in the bone (osteosarcoma, Ewing's sarcoma, chondrosarcoma). Bone metastases occur when cancer spreads to bone from elsewhere — commonly breast, lung, prostate, kidney, or thyroid cancers. Primary bone cancer needs surgery, chemotherapy, and sometimes radiation; bone metastases are treated with radiation, systemic therapy for the primary cancer, and surgical stabilisation if fracture risk is high.

Is Limb-Saving Surgery Possible For Bone Cancer?

Now the standard approach for most extremity bone tumours, limb-sparing surgery depends on tumour size, location, proximity to vessels/nerves, and response to neoadjuvant chemotherapy. Our surgical oncologist assesses each case individually based on imaging and chemo response, with the Tumour Board confirming the plan before surgery.

What Chemotherapy Is Used For Osteosarcoma?

The standard protocol (MAP) uses high-dose methotrexate, doxorubicin, and cisplatin — given before surgery to shrink the tumour and assess response, and after surgery to target remaining microscopic disease. The histological response of the surgical specimen guides the post-operative protocol.

Do I Need A Referral To See A Bone Cancer Specialist At Onco-Life?

No referral is needed. Come directly with your MRI, CT scan, bone biopsy report, or any existing imaging. If you have a suspicious bone lesion without a confirmed biopsy, we will arrange the investigation from the beginning.

Is Sbrt Effective For Bone Metastases Pain?

Yes. SBRT for bone metastases delivers a high, targeted dose to the lesion in 1 to 5 sessions and achieves durable local control and pain relief in the majority of patients. It is particularly effective for metastases in the spine, pelvis, and long bones. The pain response typically develops over 2 to 6 weeks after treatment. Our radiation oncology team assesses each case individually before planning the treatment.

Cancer Types We Treat